RA CAPITAL MANAGEMENT, L.P. - 04 Nov 2025 SCHEDULE 13G Report for BioCryst Pharmaceuticals, Inc. Common Stock, $0.01 par value per share (BCRX)

Filing Manager
RA CAPITAL MANAGEMENT, L.P.
Reporting Manager
RA Capital Management, L.P.
Security
BioCryst Pharmaceuticals, Inc. Common Stock, $0.01 par value per share
Symbol
BCRX
Shares outstanding
209,618,986 shares
Disclosed Ownership
15,302,186 shares
Ownership
7.3%
Form type
SCHEDULE 13G
Filing time
12 Nov 2025, 20:27:03 UTC
Date of event
04 Nov 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
RA Capital Management, L.P. 7.3% 15,302,186 0 15,302,186 /s/ Peter Kolchinsky By Peter Kolchinsky, Authorized Signatory
Peter Kolchinsky 7.3% 15,302,186 0 15,302,186 /s/ Peter Kolchinsky Peter Kolchinsky
Rajeev Shah 7.3% 15,302,186 0 15,302,186 /s/ Rajeev Shah Rajeev Shah
RA Capital Healthcare Fund, L.P. 7.3% 15,302,186 0 15,302,186 /s/ Peter Kolchinsky By RA Capital Healthcare Fund GP, LLC, its General Partner, By Peter Kolchinsky, Manager